The cyanobacterium Arthrospira platensis (AP) is a natural source of considerable amounts of ingredients that are relevant for nutra- and pharmaceutical uses. Beyond its nutritionally valuable components, such as carbohydrates, minerals, and proteins, bioactive ingredients extracted from AP have been studied for their therapeutical values.
Get full access to this article
View all access options for this article.
References
1.
JungF, Krüger-GengeA, WaldeckP, KüpperJ-H. Spirulina platensis, a super food?J Cell Biotechnology. 2019;5:43–54.
2.
JungF, BrauneS, JungCHG, Krüger-GengeA, WaldeckP, PetrickI, KüpperJ-H. Lipophilic and hydrophilic compounds from Arthrospira platensis and its effects on tissue and blood cells—an overview. Life. 2022;12:1497. doi.org/10.3390/life12101497.
3.
LiuQ, HuangY, ZhangR, CaiT, CaiY. Medical application of Spirulina platensis derived C-phycocyanin. J Evid Based Complementary Altern Med. 2016. Article ID 7803846, doi.org/10.1155/2016/7803846.
4.
McCartyMF. Clinical potential of Spirulina as a source of phycocyanobilin. J Med Food. 2007;10(4):566–70.
5.
BhatVB, MadyasthaKM. C-phyocyanin: A potent peroxyl radical scavenger in vitro and in vivo. Biochem Biophys Res Commun. 2000;275:20–5.
6.
Pinero EstradaJE, Bermejo BescosP, Villar del FresnoAM. Antioxidant activity of different fractions of Spirulina platensis protean extract. Farmaco. 2001;56:497–500.
7.
TakashiH, MikiyaT, MasakiO, TeppeiT, MorihikoS. Antioxidant activities of phycocyanobilin prepared from Spirulina platensis. J Appl Phycol. 2000;12:435–9.
8.
RomayC, ArmestoJ, RemirezD, GonzalezR, LedonN, GarcisI. Antioxidant and antiinflammatory properties of Cphycocyanin from blue green algae. Inflamm. Res. 1998;47:36–41.
9.
RomayC, LedónN, GonzálezR. Further studies on anti-inflammatory activity of phycocyanin in some animal models of inflammation. Inflamm Res. 1998;47:334–8.
10.
BrauneS, Krüger-GengeA, KammererS, JungF, KüpperJ-H. Phycocyanin from arthrospira platensis as potential anti-cancer drug: Review of in vitro and in vivo studies. Life. 2021;11:91. https://doi.org/10.3390/life11020091
11.
MisitiF, Carelli-AlinoviC, RodioA. ATP release from erythrocytes: A role of adenosine. Clin Hemorheol Microcirc. 2022;80(2):61–71.
12.
ArihanO, NaderE, OtoG, KocakY, FortR, ConnesP. Aqueous extract of chives (Allium schoenoprasum L.) plant impairs erythrocyte deformability in sickle cell patients. Clin Hemorheol Microcirc. 2021;79(2):357–61.
13.
MikiM, TamaiH, MinoM, YamamotoY, NikiE. Free-radical chain oxidation of rat red blood cells by molecular oxygen and its inhibition by a-tocopherol. Arch Biochem Biophys. 1987;258:373–80.
14.
NikiE, KomuroE, TakahashiM, UranoS, ItoE, TeraoK. Oxidative hemolysis of erythrocytes and its inhibition by free radical scavengers. J Biol Chem. 1988;263:19809–14.
15.
RomayC, GonzalezA. Phycocyanin is an antioxidant protector of human erythrocytes against lysis by peroxyl radicals. J Pharm Pharmacol. 2000;52:367–8.
16.
ChenT, WongY-S. In vitro antioxidant and antiproliferative activities of selenium-containing phycocyanin from selenium-enriched Spirulina platensis. J Agric Food Chem. 2008;56:4352–8.
17.
RomayC, LedonN, GonzalezR. Further studies on anti-inflammatory activity of phycocyanin in some animal models of inflammation. Inflamm Res. 1998;47:334–8.
CherngS-C, ChengS-N, TarnA, ChouT-C. Anti-inflammatory activity of c-phycocyanin in lipopolysaccharide-stimulated RAW 264.7 macrophages. Life Sci. 2007;81:1431–5.
20.
FurieB, FurieBC. Mechanisms of thrombus formation. N Engl J Med. 2008;359:938–49.
21.
KoukourakiP, TsouprasA, SotiroudisG, DemopoulosKA, SotiroudisTG. Antithrombotic properties of Spirulina extracts against platelet-activating factor and thrombin. Food Biosci. 2020;37:100686.
22.
ChiuH-F, YangS-P, KuoY-L, LaiYS, ChouT-C. Mechanisms involved in the antiplatelet effect of C-phycocyanin. Br J Nutr. 2006;95:435–40.
23.
HsiaoG, ChouP-H, ShenM-Y, ChouD-S, LinC-H, SheuJ-R. C-Phycocyanin, a very Potent and Novel Platelet Aggregation Inhibitor from Spirulina platensis. J Agric Food Chem. 2005;53:7734–40.
24.
JensenGS, DrapeauC, LenningerM, BensonKF. Clinical safety of a high dose of phycocyanin-enriched aqueous extract from Arthrospira (Spirulina) platensis: Results from a randomized, double-blind, placebo-controlled study with a focus on anticoagulant activity and platelet activation. J Med Food. 2016;19(7):645–53.
25.
Krüger-GengeA, BlockiA, FrankeRP, JungF. Vascular endothelial cell biology: An update. Int J Mol Sci. 2019;20(18):4411. doi: 10.3390/ijms20184411.
26.
Krüger-GengeA, SteinbrechtS, JungCGH, WestphalS, KlöpzigS, WaldeckP, KüpperJH, StorsbergJ, JungF. Arthrospira platensis accelerates the formation of an endothelial cell monolayer and protects against endothelial cell detachment after bacterial contamination. Clin Hemorheol Microcirc. 2021;78(2):151–61.
27.
IchimuraM, KatoS, TsuneyamaK, MatsutakeS, KamogawaM, HiraoE, MiyataA, MoriS, YamaguchiN, SurugaK, et al. Phycocyanin prevents hypertension and low serum adiponectin level in a rat model of metabolic syndrome. Nutr Res. 2013;33:397–405.
28.
Paredes-CarbajalMC, Torres-DuránPV, Díaz-ZagoyaJC, MascherD, Juárez-OropezaMA. Effects of dietary Spirulina maxima on endothelium dependent vasomotor responses of rat aortic rings. Life Sci. 1997;61:PL211–9.
29.
Kim-ShapiroDB, GladwinMT. Nitric oxide pathology and therapeutics in sickle cell disease. Clin Hemorheol Microcirc. 2018;68:223–37.
30.
MetaxaE, MengH, KaluvalaSR, SzymanskiMP, PaluchRA, KolegaJ. Nitric oxide-dependent stimulation of endothelial cell proliferation by sustained high flow. Am J Physiol Heart Circ Physiol. 2008;295:H736–42.
31.
PattarayanD, RajarajanD, SivananthamA, PalanichamyR, RajasekaranS. C-phycocyanin suppresses transforming growth factor-β1-induced epithelial mesenchymal transition in human epithelial cells. Pharmacol Rep. 2017;69(3):426–31.
32.
LiXL, XuG, ChenT, WongYS, ZhaoHL, FanRR, et al. Phycocyanin protects INS-1E pancreatic beta cells against human islet amyloid polypeptide-induced apoptosis through attenuating oxidative stress and modulating JNK and p38 mitogen-activated protein kinase pathways. Int J Biochem Cell Biol. 2009;41(7):1526–35.
33.
Krüger-GengeA, JungC, BrauneS, HarbK, WestphalS, KlöpzigS, KüpperJH, JungF. Effect of Arthrospira powders from different producers on the formation of endothelial cell monolayers. Clin Hemorheol Microcirc. 2021;79:193–203.
34.
LiuQ, HuangY, ZhangR, CaiT, CaiY. Medical Application of Spirulina platensis Derived C-Phycocyanin. J Evid Based Complementary Altern Med. 2016;2016:7803846.
35.
SalazarM, MartínezE, MadrigalE, RuizLE, ChamorroGA. Subchronic toxicity study in mice fed Spirulina maxima. J Ethnopharmacol. 1998;62(3):235–41.
36.
SoniB, VisavadiyaNP, DalwadiN, MadamwarD, WinderC, KhalilC. Purified C-phycoerythrin: Safety studies in rats and protective role against permanganate-mediated fibroblast-DNA damage. J Appl Toxicol. 2010;30(6):542–50.
37.
NaiduKA, SaradaR, ManojG, KhanMY, SwamyMM, ViswanathaS, MurthyKN, RavishankarGA, SrinivasL. Toxicity assessment of phycocyanin - A blue colorant from blue green alga Spirulina platensis. Food Biotechnol. 1999;13(1):51–66.
38.
OuY, LinL, PanQ, YangX, ChengX. Preventive effect of phycocyanin from Spirulina platensis on alloxan-injured mice. Environ Toxicol Pharmacol. 2012;34(3):721–6.
39.
GuptaM, DwivediUN, KhandelwalS. C-phycocyanin: An effective protective agent against thymic atrophy by tributyltin. Toxicol Lett. 2011;204(1):2–11.
40.
VadirajaBB, GaikwadNW, MadyasthaKM. Hepatoprotective effect of C-phycocyanin: Protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats. Biochem Biophys Res Commun. 1998;249(2):428–31.
41.
BelayA, KatoT, OtaY. Spirulina (Arthrospira): Potential application as an animal feed supplement. J Appl Phycol. 1996;8:303–11.
42.
SalazarM, ChamorroG, SalazarS, SteeleC. Effect of Spirulina maxima consumption on reproductive and peri- and postnatal development in rats. Food Chem Toxicol. 1996;353–9.
43.
TarantinoLM. Agency Response Letter GRAS Notice No. GRN000127, FDA Home page, 2003.
44.
BelayA. The potential application of Spirulina (Arthrospira) as a nutritional and therapeutic supplement in Health management. J Am Nutraceut Ass. 2002;5:27–48.
45.
CevallosCG, Lilia BarronB, Vazquez-SanchezJ. Toxicologic studies and antitoxic properties in Spirulina. In: Spirulina in Human Nutrition and Health (
GershwinME,
BelayA, eds.). CRC Press Taylor & Francis Group, Boca Raton, FL, 2008, pp. 42–6.
46.
MarlesRJ, BarrettML, BarnesJ, ChavezML, GardinerP, KoR, MahadyGB, Low DogT, SarmaND, GiancasproGI, SharafM, GriffithsJ. United States pharmacopeia safety evaluation of spirulina. Crit Rev Food Sci Nutr. 2011;51(7):593–604.
